Rodolfo San Antonio
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Rodolfo San Antonio has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
- Eduardo Flores-Umanzor
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
6 shared publications Guillem Caldentey
University of Barcelona, Cardiology Department, Cardiovascular Institute, Barcelona, Spain
3 shared publicationsVictoria Martin-Yuste
University of Barcelona, Cardiology Department, Cardiovascular Institute, Barcelona, Spain
3 shared publicationsEduard Guasch
Department of Cardiology, Cardiovascular Clinical Institute, Arrhythmia Unit, Hospital Clinic, Universitat de Barcelona, Barcelona, Catalonia, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain
2 shared publicationsFrancisco Alarcón
Department of Cardiology, Cardiovascular Clinical Institute, Arrhythmia Unit, Hospital Clinic, Universitat de Barcelona, Barcelona, Catalonia, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain
2 shared publicationsGustavo Jimenez-Britez
University of Barcelona, Cardiology Department, Cardiovascular Institute, Barcelona, Spain
2 shared publications
Latest Publications
- Open Access
- 2 August 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (15) , 6012
Cardioneuroablation for Reflex Syncope and Functional Bradyarrhythmias: A State-of-the-Art Review
Cardioneuroablation (CNA), defined as endocardial catheter ablation of atrial ganglionated plexi within the intrinsic cardiac autonomic nervous system, has emerged as a mechanism-directed therapy for cardioinhibitory reflex syncope and functional bradyarrhythmias. By attenuating postganglionic parasympathetic input to the sinoatrial and atrioventricular nodes, CNA targets the autonomic substrate of cardioinhibition rather than merely treating its bradycardic consequence. Over the past two decades, the evidence base has progressed from pioneering single-center experiences to multicenter registries, systematic reviews, meta-analyses, and randomized clinical trials, with reported freedom from recurrent syncope of approximately 80–94% in carefully selected patients at medium-term follow-up. This state-of-the-art narrative review summarizes the rationale, anatomy, patient-selection principles, mapping and ablation strategies, procedural endpoints, clinical outcomes, safety profile, and emerging applications of CNA. Particular emphasis is placed on the unresolved questions that will define the future of the field: the absence, to date, of adequately powered sham-controlled efficacy data; the lack of a universally validated intraprocedural endpoint; the biological and clinical significance of vagal reinnervation; and the gap between expert-center and broader real-world outcomes. Current evidence supports CNA as a promising, anatomically grounded neuromodulatory therapy, but its transition from expert-center innovation to guideline-endorsed treatment will depend on rigorous patient selection, standardized procedural endpoints, and the results of ongoing randomized trials.
- 2 August 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (15) , 6012
Open AccessCardioneuroablation for Reflex Syncope and Functional Bradyarrhythmias: A State-of-the-Art Review
Cardioneuroablation (CNA), defined as endocardial catheter ablation of atrial ganglionated plexi within the intrinsic cardiac autonomic nervous system, has emerged as a mechanism-directed therapy for cardioinhibitory reflex syncope and functional bradyarrhythmias. By attenuating postganglionic parasympathetic input to the sinoatrial and atrioventricular nodes, CNA targets the autonomic substrate of cardioinhibition rather than merely treating its bradycardic consequence. Over the past two decades, the evidence base has progressed from pioneering single-center experiences to multicenter registries, systematic reviews, meta-analyses, and randomized clinical trials, with reported freedom from recurrent syncope of approximately 80–94% in carefully selected patients at medium-term follow-up. This state-of-the-art narrative review summarizes the rationale, anatomy, patient-selection principles, mapping and ablation strategies, procedural endpoints, clinical outcomes, safety profile, and emerging applications of CNA. Particular emphasis is placed on the unresolved questions that will define the future of the field: the absence, to date, of adequately powered sham-controlled efficacy data; the lack of a universally validated intraprocedural endpoint; the biological and clinical significance of vagal reinnervation; and the gap between expert-center and broader real-world outcomes. Current evidence supports CNA as a promising, anatomically grounded neuromodulatory therapy, but its transition from expert-center innovation to guideline-endorsed treatment will depend on rigorous patient selection, standardized procedural endpoints, and the results of ongoing randomized trials.
- Open Access
- 15 June 2026
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 69 (9) , 2679-2680
Sequential radiofrequency–pulsed field ablation of a refractory right posteroseptal accessory pathway using a dual-energy catheter
- 15 June 2026
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 69 (9) , 2679-2680
Open AccessSequential radiofrequency–pulsed field ablation of a refractory right posteroseptal accessory pathway using a dual-energy catheter
- Open Access
- 1 May 2023
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 25 (5)
Personalized pulmonary vein antrum isolation guided by left atrial wall thickness for persistent atrial fibrillation
Pulmonary vein (PV) antrum isolation proved to be effective for treating persistent atrial fibrillation (PeAF). We sought to investigate the results of a personalized approach aimed at adapting the ablation index (AI) to the local left atrial wall thickness (LAWT) in a cohort of consecutive patients with PeAF. Consecutive patients referred for PeAF first ablation were prospectively enrolled. The LAWT three-dimensional maps were obtained from pre-procedure multidetector computed tomography and integrated into the navigation system. Ablation index was titrated according to the local LAWT, and the ablation line was personalized to avoid the thickest regions while encircling the PV antrum. A total of 121 patients (69.4% male, age 64.5 ± 9.5 years) were included. Procedure time was 57 min (IQR 50–67), fluoroscopy time was 43 s (IQR 20–71), and radiofrequency (RF) time was 16.5 min (IQR 14.3–18.4). The median AI tailored to the local LAWT was 387 (IQR 360–410) for the anterior wall and 335 (IQR 300–375) for the posterior wall. First-pass PV antrum isolation was obtained in 103 (85%) of the right PVs and 103 (85%) of the left PVs. Median LAWT values were higher for PVs without first-pass isolation as compared to the whole cohort (P = 0.02 for left PVs and P = 0.03 for right PVs). Recurrence-free survival was 79% at 12 month follow-up. In this prospective study, LAWT-guided PV antrum isolation for PeAF was effective and efficient, requiring low procedure, fluoroscopy, and RF time. A randomized trial comparing the LAWT-guided ablation with the standard of practice is in progress (ClinicalTrials.gov, NCT05396534).
- 1 May 2023
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 25 (5)
Open AccessPersonalized pulmonary vein antrum isolation guided by left atrial wall thickness for persistent atrial fibrillation
Pulmonary vein (PV) antrum isolation proved to be effective for treating persistent atrial fibrillation (PeAF). We sought to investigate the results of a personalized approach aimed at adapting the ablation index (AI) to the local left atrial wall thickness (LAWT) in a cohort of consecutive patients with PeAF. Consecutive patients referred for PeAF first ablation were prospectively enrolled. The LAWT three-dimensional maps were obtained from pre-procedure multidetector computed tomography and integrated into the navigation system. Ablation index was titrated according to the local LAWT, and the ablation line was personalized to avoid the thickest regions while encircling the PV antrum. A total of 121 patients (69.4% male, age 64.5 ± 9.5 years) were included. Procedure time was 57 min (IQR 50–67), fluoroscopy time was 43 s (IQR 20–71), and radiofrequency (RF) time was 16.5 min (IQR 14.3–18.4). The median AI tailored to the local LAWT was 387 (IQR 360–410) for the anterior wall and 335 (IQR 300–375) for the posterior wall. First-pass PV antrum isolation was obtained in 103 (85%) of the right PVs and 103 (85%) of the left PVs. Median LAWT values were higher for PVs without first-pass isolation as compared to the whole cohort (P = 0.02 for left PVs and P = 0.03 for right PVs). Recurrence-free survival was 79% at 12 month follow-up. In this prospective study, LAWT-guided PV antrum isolation for PeAF was effective and efficient, requiring low procedure, fluoroscopy, and RF time. A randomized trial comparing the LAWT-guided ablation with the standard of practice is in progress (ClinicalTrials.gov, NCT05396534).
- Open Access
- 13 April 2023
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 68 (2) , 215-217
Time for a paradigm shift: from pacing to ablation in reflex syncope
- 13 April 2023
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 68 (2) , 215-217
Open AccessTime for a paradigm shift: from pacing to ablation in reflex syncope
- Open Access
- 1 June 2021
- Published by Elsevier in Heart Rhythm
- Vol. 18 (6) , 896-904
Ventricular tachycardia burden reduction after substrate ablation: Predictors of recurrence
- 1 June 2021
- Published by Elsevier in Heart Rhythm
- Vol. 18 (6) , 896-904
Open AccessVentricular tachycardia burden reduction after substrate ablation: Predictors of recurrence
- 24 March 2020
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 22 (5) , 776
Subcutaneous implantable cardioverter-defibrillator infection affecting deep tissues: is it always mandatory to remove the device?
- 24 March 2020
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 22 (5) , 776
Subcutaneous implantable cardioverter-defibrillator infection affecting deep tissues: is it always mandatory to remove the device?
- 1 December 2019
- Published by Elsevier in Heart Rhythm
- Vol. 16 (12) , 1849-1854
Management of anticoagulation in patients undergoing leadless pacemaker implantation
- 1 December 2019
- Published by Elsevier in Heart Rhythm
- Vol. 16 (12) , 1849-1854
Management of anticoagulation in patients undergoing leadless pacemaker implantation
- Open Access
- 22 October 2019
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 3 (4) , 1-5
Undetected displacement of a subcutaneous implantable cardioverter-defibrillator lead. importance of performing a chest X-ray during the first weeks post-implant: a case report
Background: In recent years, subcutaneous implantable cardioverter-defibrillator (S-ICD) implants have progressively increased and have been shown to be safe and highly successful, affording low reintervention rates regardless of the technique used. Case summary: We present a case of S-ICD implantation in a patient diagnosed with idiopathic ventricular fibrillation. In the first follow-up consultation the patient showed appropriate detection parameters in the three configurations. However, chest X-ray revealed lead displacement with a tip migration from the manubrium area of the sternum to the xiphoid process. Discussion: This case highlights the importance of performing at least one chest X-ray during the first weeks after S-ICD implantation, allowing the detection of a problem such as lead displacement, which can lead to undersensing of ventricular arrhythmias or S-ICD oversensing.
- 22 October 2019
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 3 (4) , 1-5
Open AccessUndetected displacement of a subcutaneous implantable cardioverter-defibrillator lead. importance of performing a chest X-ray during the first weeks post-implant: a case report
Background: In recent years, subcutaneous implantable cardioverter-defibrillator (S-ICD) implants have progressively increased and have been shown to be safe and highly successful, affording low reintervention rates regardless of the technique used. Case summary: We present a case of S-ICD implantation in a patient diagnosed with idiopathic ventricular fibrillation. In the first follow-up consultation the patient showed appropriate detection parameters in the three configurations. However, chest X-ray revealed lead displacement with a tip migration from the manubrium area of the sternum to the xiphoid process. Discussion: This case highlights the importance of performing at least one chest X-ray during the first weeks after S-ICD implantation, allowing the detection of a problem such as lead displacement, which can lead to undersensing of ventricular arrhythmias or S-ICD oversensing.
- Open Access
- 30 October 2018
- Published by Elsevier in Revista Portuguesa de Cardiologia (English Edition)
- Vol. 37 (10) , 865.e1-865.e4
Percutaneous coronary intervention due to chronic total occlusion in the left main coronary artery after bypass grafting: A feasible option in selected cases
- 30 October 2018
- Published by Elsevier in Revista Portuguesa de Cardiologia (English Edition)
- Vol. 37 (10) , 865.e1-865.e4
Open AccessPercutaneous coronary intervention due to chronic total occlusion in the left main coronary artery after bypass grafting: A feasible option in selected cases
- Open Access
- 1 October 2018
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 37 (10) , 865.e1-865.e4
Percutaneous coronary intervention due to chronic total occlusion in the left main coronary artery after bypass grafting: A feasible option in selected cases
- 1 October 2018
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 37 (10) , 865.e1-865.e4
Open AccessPercutaneous coronary intervention due to chronic total occlusion in the left main coronary artery after bypass grafting: A feasible option in selected cases